What is the maintenance infusion rate in mL/hour of tirofiban for a patient with acute coronary syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tirofiban Maintenance Infusion Rate in Acute Coronary Syndrome

For a patient with acute coronary syndrome undergoing PCI, administer tirofiban at a maintenance infusion rate of 0.15 mcg/kg/min, which translates to 9 mL/hour for a 60 kg patient using the standard 50 mcg/mL concentration (250 mL premixed bag). 1

Standard Dosing Calculation

The maintenance infusion rate in mL/hour is calculated using the following formula from the FDA label 1:

Infusion rate (mL/hour) = [0.15 mcg/kg/min × patient weight (kg) × 60 min/hour] ÷ 50 mcg/mL

Examples:

  • 60 kg patient: (0.15 × 60 × 60) ÷ 50 = 10.8 mL/hour 1
  • 70 kg patient: (0.15 × 70 × 60) ÷ 50 = 12.6 mL/hour 1
  • 80 kg patient: (0.15 × 80 × 60) ÷ 50 = 14.4 mL/hour 1

Dosing Protocol

Initial bolus: 25 mcg/kg administered intravenously within 5 minutes, followed immediately by the maintenance infusion 1, 2

Duration: Continue infusion for up to 18 hours post-PCI 1, 2

Timing: Initiate tirofiban just prior to or during PCI, not in the pre-catheterization laboratory setting unless specifically indicated 3

Critical Dose Adjustment for Renal Impairment

For patients with creatinine clearance ≤ 60 mL/min, reduce the maintenance infusion rate by 50% to 0.075 mcg/kg/min 1, 2

This adjustment is essential because tirofiban's half-life is prolonged more than three-fold in severe renal insufficiency, significantly increasing bleeding risk without dose reduction 3, 4

Adjusted calculation for renal impairment:

Infusion rate (mL/hour) = [0.075 mcg/kg/min × patient weight (kg) × 60 min/hour] ÷ 50 mcg/mL

  • 60 kg patient with CrCl ≤ 60: (0.075 × 60 × 60) ÷ 50 = 5.4 mL/hour 1
  • 70 kg patient with CrCl ≤ 60: (0.075 × 70 × 60) ÷ 50 = 6.3 mL/hour 1

Important Clinical Considerations

Concomitant anticoagulation: When using tirofiban with heparin during PCI, administer weight-adjusted heparin (60 IU/kg bolus, maximum 4,000 IU) targeting an ACT of 200-250 seconds 3, 2

Platelet monitoring: Check platelet counts beginning 6 hours after treatment initiation and daily thereafter; discontinue if platelets drop below 90,000/mm³ 1

Bleeding risk: Major bleeding rates with weight-adjusted tirofiban dosing are not significantly different from heparin alone when dosed appropriately 3, 5

Common Pitfalls to Avoid

Do not use the older low-dose regimen (0.4 mcg/kg/min bolus for 30 minutes followed by 0.1 mcg/kg/min maintenance) as this was replaced by the high-dose bolus regimen that achieves >80% platelet inhibition within 5 minutes 2, 3

Do not forget renal dose adjustment: Failure to reduce the infusion rate by 50% in patients with CrCl ≤ 60 mL/min substantially increases bleeding complications 1, 3

Calculate creatinine clearance using actual body weight with the Cockcroft-Gault equation before initiating therapy 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.